Platelet and fibrin clots occlude blood vessels in hemostasis and thrombosis. Here we report a noncanonical mechanism for vascular occlusion based on neutrophil extracellular traps (NETs), DNA fibers released by neutrophils during inflammation. We investigated which host factors control NETs in vivo and found that two deoxyribonucleases (DNases), DNase1 and DNase1-like 3, degraded NETs in circulation during sterile neutrophilia and septicemia. In the absence of both DNases, intravascular NETs formed clots that obstructed blood vessels and caused organ damage. Vascular occlusions in patients with severe bacterial infections were associated with a defect to degrade NETs ex vivo and the formation of intravascular NET clots. DNase1 and DNase1-like 3 are independently expressed and thus provide dual host protection against deleterious effects of intravascular NETs.
I
nflammation is an essential host response for the control of invading microbes and healing of damaged tissues (1) . Uncontrolled and persistent inflammation causes tissue injury in a plethora of inflammatory disorders. Neutrophils are the predominant leukocytes present during acute inflammation. During infections, neutrophils generate extracellular traps (NETs), lattices of DNA filaments decorated with toxic histones and enzymes that immobilize and neutralize bacteria (2) . Extracellular deoxyribonucleases (DNases) serve as virulence factors in several pathogenic bacteria, demonstrating the relevance of NETs in host defense (3, 4) . However, inappropriately released NETs may harm host cells as a result of their cytotoxic, proinflammatory, and prothrombotic activity (5) (6) (7) . Indeed, NETs are frequently associated with inflammatory or ischemic organ damage, and the therapeutic infusion of DNases limits host injury in various animal models (8, 9) .
How the host degrades NETs in vivo to limit tissue damage during episodes of inflammation is poorly understood. Earlier work has shown that DNase1 in serum digests the DNA backbone of NETs in vitro (10) . We analyzed serum from wild-type mice by zymography and detected two enzymatically active DNases, DNase1 and DNase1-like 3 (DNase1L3) (Fig. 1A) . Both enzymes are members of the DNase1 protein family, but differ in their origin and substrate affinity. DNase1 is expressed by nonhematopoietic tissues and preferentially cleaves protein-free DNA (11, 12) . DNase1L3, also known as DNase gamma, is secreted by immune cells and targets DNA-protein complexes, such as nucleosomes (11, 13) . We generated mice that lacked DNA-degrading activity in serum due to a combined deficiency of DNase1 and DNase1L3 (Fig. 1A) . In vitro-generated NETs remained intact after exposure to Dnase1 -/-Dnase1l3 -/-sera, whereas sera from wild-type, Dnase1 -/-, and Dnase1l3 -/-mice degraded NETs (Fig. 1, B and C) . We then stably expressed Dnase1 or Dnase1l3 cDNA in the livers of Dnase1 -/-Dnase1l3 -/-mice. Given that both enzymes contain a secretory protein signal sequence (11) , this approach restored the activity of DNase1 or DNase1L3 in circulation (Fig. 1D ) and the capacity of sera from Dnase1 -/-Dnase1l3 -/-Dnase1l3 -/-mice with the granulocyte colony-stimulating factor (G-CSF), which triggers neutrophilia-a hallmark of acute inflammationand stimulates a subpopulation of neutrophils to spontaneously release NETs ex vivo (14) . Hepatic expression of Csf3 cDNA, which encodes G-CSF, resulted in chronically elevated concentrations of G-CSF in plasma ( fig. S1A ). Consequently, the neutrophil blood count steadily increased, and spontaneously formed NETs were detected in 1 of 5 WT D1 (Fig. 2, A and B) . There was also an increased number of resident neutrophils in vital organs and splenomegaly ( fig. S1 , B and C). -/-Dnase1l3 -/-mice coexpressing Csf 3 with a control plasmid lacking both Dnase1 and Dnase1l3 died within 5 days after gene delivery (Fig. 2D ). The mortality in these mice was preceded by a rapidly progressing hypothermia, which was evidenced as a strong decrease in peripheral body temperature within 8 hours before exitus (Fig. 2E) . Hypothermia was accompanied with hemolytic anemia, shown by reddish plasma and urine and reduced blood hemoglobin (Fig. 2 , F and G). Abundant schistocytes in blood smears indicated that the hemolytic anemia was caused by erythrocyte fragmentation (Fig. 2H) . Furthermore, we detected elevated plasma concentrations of lactate dehydrogenase (LDH), liver transaminases, and the renal-injury markers blood urea nitrogen and creatinine, which indicated multiple-organ damage ( Fig. 2I and fig. S2 , A and B). Coexpression of Dnase1 or Dnase1l3 with Csf 3 maintained the body temperature and integrity of erythrocytes and organs despite neutrophilia (Fig. 2, E to I, and fig. S2 , A to C). Thus, either DNase1 or DNase1L3 is required to prevent host injury during chronic neutrophilia.
Dnase1 -/-Dnase1l3 -/-mice with chronic neutrophilia showed intravascular hematoxylinpositive clots with entrapped erythrocytes that fully or partially occluded blood vessels in lungs, liver, and kidneys (Fig. 3, A and B, and fig. S2 , D to G). The expression of DNase1 or DNase1L3 in circulation prevented these vascular occlusions. The hematoxylin-positive clots showed an abundant light violet staining pattern that was sporadically speckled with the dark violet staining of individual leukocyte nuclei, suggesting that decondensed DNA was a major clot component (Fig. 3A) . Given that nuclear breakdown and the unfolding of tightly packed chromatin is a hallmark of NET formation (15), we stained the hematoxylinpositive clots for NET markers. We observed a robust staining with fluorescent double-stranded DNA-intercalating dyes and antibodies against chromatin ( fig. S3A ). The colocalization of decondensed chromatin with the neutrophil granulederived enzyme myeloperoxidase, antimicrobial cathelicidin peptides, and the NET surrogate markers citrullinated histones confirmed that the clots were composed of NETs (Fig. 3C and  fig. S3 , B and C). To identify components of canonical thrombi, we stained NET clots for fibrin and von Willebrand factor (vWF), a protein stored in the secretory vesicles of platelets and the vascular endothelium. NET clots were very heterogeneous in their vWF and fibrin content (Fig. 3, D and E). Cross sections of NET clots were covered with 45.7 ± 27.1% of vWF and 3.4 ± 4.4% of fibrin, whereas 9.6 ± 8.4% of NET clots stained for neither vWF nor fibrin (means ± SD, N = 4 mice). Indeed, NETs serve as a fibrin-independent scaffold to immobilize platelets and erythrocytes in vitro (6) . The absence of vWF and fibrin in some clots suggested that NETs may be sufficient for vascular occlusion. To corroborate this notion, we aimed to generate NET clots from pure neutrophils in vitro. We isolated neutrophils from blood and induced NET formation, while exposing the cells to shear forces to mimic blood flow. We observed macroscopically visible and DNasesensitive clots ( fig. S4A) , which resembled the appearance of NET clots within the murine vasculature ( fig. S4B ). Now, we depleted platelets from the circulation and pharmacologically inhibited thrombin in Csf 3-expressing Dnase1
Dnase1l3
-/-mice. Unlike DNase1 or DNase1L3 expression, neither antithrombotic treatment was sufficient to prevent mortality in these animals (Fig. 3F) . Thus, NET clots are sufficient to obstruct blood vessels during chronic neutrophilia in Dnase1
-/-Dnase1l3 -/-mice. The formation of NET clots in Dnase1
-/-mice was associated with features of infection-induced thrombotic microangiopathies (TMAs) and disseminated intravascular coagulation in patients, including schistocytes, hemolytic anemia, and organ failure due to vascular occlusions. We analyzed plasma from TMA patients with hemolytic-uremic syndrome resulting from an infection with Shiga toxin-producing Escherichia coli [STEC-HUS, (16)]. Sepsis and septic shock is a frequent complication in these patients (17) . NETs generated in vitro remained intact after exposure to patient plasma collected in the acute disease state (18, 19) , whereas plasma from patients in remission degraded NETs ( fig.  S5, A and B) . The data suggest an acquired and temporary defect in NET degradation. Notably, STEC-HUS patients are effectively treated with a regimen that includes infusion of plasma from healthy donors (17) , a source of DNases, which restored NET degradation in vitro ( fig. S5, C and D) .
Large aggregates of NETs are reportedly formed in the synovial fluid and pancreatic ducts of patients (20, 21) but have not yet been described in other tissues. Therefore, we aimed to identify intravascular aggregates of NETs in patients with severe inflammatory diseases. We screened lung tissue collected at autopsy from patients with acute respiratory distress syndrome and/or sepsis (table S1). We detected hematoxylin-positive clots in the blood vessels of two septic patients ( fig. S6,  A and C) . In both cases, clots comprised chromatin and myeloperoxidase ( fig. S6, B and D that NETs can form intravascular clots in human sepsis. Septicemia is a potent and rapid trigger of intravascular NET formation in mice (5) . Thus, we hypothesized that a defect in NET degradation may aggravate the disease. Indeed, mice with a combined deficiency in DNase1 and DNase1L3, but not wild-type mice, were highly susceptible to low doses of lipopolysaccharide and heat-killed E. coli (Fig. 4A) . Similar to neutrophilic Dnase1
-/-mice, blood analysis of septic Dnase1
-/-mice showed hemolytic anemia and hematuria (Fig. 4 , B and C), along with increased concentrations of plasma LDH and schistocytes in blood smears (Fig. 4, D and E) . Furthermore, we detected abundant partially or fully occluded blood vessels in the lung (Fig. 4, F to H) . A detailed analysis of partially occluded vessels revealed NET clots within the vascular lumen (Fig. 4I) . In fully occluded vessels, the NET clots were congested with entrapped erythrocytes and leukocytes ( Fig. 4I and fig. S7, A and B) . Hepatic expression of Dnase1 or Dnase1l3 in Dnase1
-/-mice prevented vascular occlusion and restored the wild-type phenotype. Thus, circulating DNase1 or DNase1L3 prevent the formation of NET clots and host injury in septicemia.
Although platelets and fibrin form hemostatic clots and pathological thrombi (22) , our data introduce NET clots as a noncanonical mechanism for vascular occlusion in inflammatory states. Similar to fibrin strands, NETs are large and stable molecules (6) . At high concentrations, such as are found in chronic neutrophilia or septicemia, intravascular NETs may form clots, which are sufficient in size to obstruct blood vessels and thus cause damage to erythrocytes and organs. To maintain blood and tissue integrity during inflammation, the host independently expresses DNase1 and DNase1L3 as a dual-protection system against intravascular NETs. However, acquired and genetic defects in these host factors may delay the degradation of NETs and thus precipitate disease. Acquired defects may involve DNase1 inhibition by monomeric actin externalized from damaged tissue and the inactivation of DNase1L3 by serum proteases (11) . Mutations in Dnase1 and Dnase1l3 have been identified in patients and are associated with systemic lupus erythematosus (SLE), an autoimmune disease (23, 24) , and DNase1-and DNase1L3-deficient mice spontaneously develop SLE-like disease with age (13, 25) . NETs are composed of prominent autoantigens, and neutrophils from SLE patients have an increased capacity to release NETs (26) . A reduced clearance capacity may increase the half-life of NETs and thus promote autoimmune disease (10, 27) . In conclusion, primary as well as secondary defects in NET degradation may contribute to host injury in a plethora of inflammatory diseases. (A) log-rank test, **P < 0.01 versus all other groups; (B) to (F) one-way ANOVA followed by Bonferroni's multiple comparisons post hoc test, ***P < 0.001, **P < 0.01.
